Tech Company Financing Transactions
RxAnte Funding Round
RxAnte closed a Series A financing round on 9/13/2012. Backers included Aberdare Ventures and West Health Investment Fund.
Transaction Overview
Company Name
Announced On
9/13/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Aberdare Ventures (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
2233 Wisconsin Ave. NW 502
Washington, DC 20007
USA
Washington, DC 20007
USA
Phone
Website
Email Address
Overview
Four out of five physician visits end with a prescription being written. Yet for many patients with chronic conditions, complications arise, health deteriorates, and costs spiral -- all because potentially effective medications are not taken as prescribed.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Benner
Chief Operating Officer
Peter Aldrich
Vice President
Loren Lidsky
Vice President
Adam Steinberg
VP - Bus. Development
Steve Nickerson
VP - Client Services
Kerri Petrin
VP - Finance
Corbin Director
VP - General Counsel
Eileen Casal
VP - Product Management
Amie Joyce
Browse more venture capital transactions:
Prev: 9/13/2012: Xtone venture capital transaction
Next: 9/13/2012: Traitify venture capital transaction
Share this article
News on VC Transactions
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs